(Q34423696)

2 August 2017

1 reference

title

Folate, homocysteine, endothelial function and cardiovascular disease. What is the link? (English)

1 reference

2 August 2017

0 references

cardiovascular disease

1 reference

1 reference

Ashfield-Watt PA

1

1 reference

2 August 2017

Moat SJ

series ordinal

2

1 reference

2 August 2017

Doshi SN

series ordinal

3

1 reference

2 August 2017

McDowell IF

series ordinal

4

1 reference

2 August 2017

publication date

1 October 2001

1 reference

Biomedicine and Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

55

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

425-433

1 reference

The natural history of vascular disease in homocystinuria and the effects of treatment

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Homocysteine and major coronary events: a prospective population study amongst women

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Vitamin requirements for the treatment of hyperhomocysteinemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

THE METHYL FOLATE TRAP A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid-induced exacerbation of subacute combined degeneration in pernicious anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

The controversy over homocysteine and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Regulatory functions of the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Oral folate enhances endothelial function in hyperhomocysteinaemic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900125-1

7 January 2021

10.1016/S0753-3322(01)00125-1

Identifiers

DOI

1 reference

2 August 2017

1 reference